Meropenem Sun

Meropenem, the active ingredient in Meropenem Sun, is a carbapenem antibiotic presented as an injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, meningitis, severe sepsis and septic shock in hospitalized patients.

GNH USA supplies Meropenem Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a carbapenem antibiotic used to treat serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: provides broad‑spectrum coverage to eradicate Gram‑negative, Gram‑positive and anaerobic pathogens. - Complicated urinary tract infections: achieves rapid bacterial clearance in resistant uropathogens. - Nosocomial pneumonia: delivers effective treatment against hospital‑acquired respiratory pathogens. - Meningitis: penetrates the cerebrospinal fluid to eradicate causative bacteria. - Severe sepsis and septic shock: supports systemic infection control in critically ill patients.

Adverse reactions may occur with any antimicrobial therapy.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Rash or pruritus - Headache - Phlebitis at the injection site

Serious or Rare Side Effects: - Seizures, especially in patients with CNS disorders or renal impairment - Anaphylactic or severe hypersensitivity reactions - Clostridioides difficile‑associated colitis - Acute renal failure or worsening renal function - Hepatic enzyme elevation - Neutropenia or other hematologic abnormalities

Careful assessment and monitoring are required when using Meropenem.

- Renal function assessment: adjust dosing in patients with impaired renal clearance. - Hypersensitivity monitoring: observe for signs of allergic reaction during and after infusion. - CNS caution: avoid or monitor in patients with a history of seizures. - Concomitant nephrotoxic drugs: use with caution to reduce risk of renal injury. - Pregnancy and lactation: evaluate risk‑benefit ratio as safety data are limited. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, requiring clinical awareness.

Major Interactions (Avoid): - Valproic acid: carbapenems can reduce serum valproate levels, risking seizure breakthrough. - Oral contraceptives: may decrease hormonal efficacy, increasing risk of unintended pregnancy. - Probenecid: can raise meropenem plasma concentrations, heightening toxicity risk.

Moderate Interactions (Monitor Closely): - Vancomycin: combined use may increase nephrotoxicity; monitor renal function. - Warfarin: may alter INR; check coagulation parameters regularly.